Black Diamond Therapeutics Inc Cash Flow Reinvestment Rate
Black Diamond Therapeutics Inc cash flow reinvestment rate. Black Diamond Therapeutics Inc (BDTX) has a Cash Flow Reinvestment Rate of 0.16x as of March 2025, reinvesting $8.55 Million (capex $0.00 plus investments $8.55 Million) from operating cash flow of $53.41 Million. Explore debt repayment capacity of Black Diamond Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Black Diamond Therapeutics Inc (2025–2025)
Cash flow reinvestment rate of Black Diamond Therapeutics Inc from 2025 to 2025. Historical reinvestment intensity for Black Diamond Therapeutics Inc across 1 annual periods. Also explore BDTX net assets growth trend to track the company's year-over-year net asset growth rate.
Black Diamond Therapeutics Inc Cash Flow Reinvestment Rate by Year (2025–2025)
Black Diamond Therapeutics Inc cash flow reinvestment rate by year from 2025 to 2025. Year-by-year capital reinvestment analysis for Black Diamond Therapeutics Inc. For the full cash flow conversion analysis, see BDTX cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.52x | $44.93 Million | $29.61 Million | $0.00 | — |